T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
2026
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $597K | ﹤0.01% |
47,765
| – | – |
|
|
AAT
2027
American Assets Trust
AAT
$1.27B
| $595K | ﹤0.01% |
23,104
+9,363
| +68% | +$241K |
|
2028
Outset Medical
OM
$243M
| $595K | ﹤0.01% |
2,488
-187,449
| -99% | -$44.8M |
|
2029
RadNet
RDNT
$5.69B
| $595K | ﹤0.01% |
29,213
+3,721
| +15% | +$75.8K |
|
|
BRG
2030
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $595K | ﹤0.01% |
22,259
-477
| -2% | -$12.8K |
|
2031
Transmedics
TMDX
$3.91B
| $594K | ﹤0.01% |
14,224
+5,803
| +69% | +$242K |
|
2032
Emergent Biosolutions
EBS
$434M
| $592K | ﹤0.01% |
28,139
-104,788
| -79% | -$2.2M |
|
2033
SpartanNash
SPTN
$897M
| $592K | ﹤0.01% |
20,399
-3,389
| -14% | -$98.4K |
|
2034
Shore Bancshares
SHBI
$569M
| $590K | ﹤0.01% |
34,027
+16,480
| +94% | +$286K |
|
2035
Uranium Energy
UEC
$5.27B
| $588K | ﹤0.01% |
167,923
+47,012
| +39% | +$165K |
|
2036
LivePerson
LPSN
$86M
| $587K | ﹤0.01% |
62,270
+18,965
| +44% | +$179K |
|
|
BDN
2037
Brandywine Realty Trust
BDN
$789M
| $585K | ﹤0.01% |
86,644
+11,116
| +15% | +$75.1K |
|
2038
International Seaways
INSW
$2.33B
| $582K | ﹤0.01% |
16,565
-1,451,135
| -99% | -$51M |
|
2039
FuelCell Energy
FCEL
$222M
| $581K | ﹤0.01% |
5,676
+12
| +0.2% | +$1.23K |
|
2040
Fastly
FSLY
$1.14B
| $581K | ﹤0.01% |
63,375
+8,052
| +15% | +$73.8K |
|
2041
Vicor
VICR
$2.28B
| $581K | ﹤0.01% |
9,809
+1,457
| +17% | +$86.3K |
|
|
PGRE
2042
Paramount Group
PGRE
$1.57B
| $577K | ﹤0.01% |
92,543
+16,373
| +21% | +$102K |
|
|
KRON
2043
DELISTED
Kronos Bio
KRON
| $575K | ﹤0.01% |
171,186
-228,125
| -57% | -$766K |
|
2044
Live Oak Bancshares
LOB
$1.67B
| $574K | ﹤0.01% |
18,748
-5,621,359
| -100% | -$172M |
|
2045
PJT Partners
PJT
$4.47B
| $574K | ﹤0.01% |
8,582
+1,492
| +21% | +$99.8K |
|
2046
Alight
ALIT
$1.95B
| $573K | ﹤0.01% |
78,099
+22,802
| +41% | +$167K |
|
2047
EchoStar
SATS
$21.5B
| $573K | ﹤0.01% |
34,764
+4,766
| +16% | +$78.6K |
|
2048
National Beverage
FIZZ
$3.67B
| $572K | ﹤0.01% |
14,833
+3,581
| +32% | +$138K |
|
2049
Sally Beauty Holdings
SBH
$1.48B
| $568K | ﹤0.01% |
45,059
-4,062
| -8% | -$51.2K |
|
|
MTTR
2050
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $567K | ﹤0.01% |
149,585
+66,411
| +80% | +$252K |
|